 | |
| Formerly | Perrigo Inc. (before the 2013 tax inversion to Ireland) |
|---|---|
| Company type | Public |
| ISIN | IE00BGH1M568 |
| Industry | Pharmaceutical |
| Founded | 1887 as L. Perrigo Company in Allegan, Michigan, U.S. |
| Founders | Luther and Charles Perrigo |
| Headquarters |
|
Key people | Patrick Lockwood-Taylor (President and CEO) |
| Products |
|
| Revenue |  US$4.66 billion (2023) |
| US$152 million (2023) | |
 US$−13 million (2023) | |
| Total assets |  US$10.8 billion (2023) |
| Total equity | US$4.77 billion (2023) |
Number of employees | 9,140+ (2023) |
| Subsidiaries | |
| Website | perrigo |
| Footnotes / references [1] | |
Perrigo Company plc (Hebrew: פריגו) is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales.[2][3] In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes.[4] Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.[5]
Perrigo engages in the acquisition (for repricing), manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients (APIs), primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.[6][7]
- ^ "Perrigo Company plc 2023 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 27 February 2024.
- ^ Perrigo Co plc: Form 10-Q (29 September 2018). Securities and Exchange Commission. 8 November 2018. p. 9.
Disaggregation of Revenue
- ^ Automation, MarketWatch. "Perrigo Co. PLC stock rises Wednesday, still underperforms market". MarketWatch. Retrieved 22 July 2021.
- ^ Cite error: The named reference
bbbwas invoked but never defined (see the help page). - ^ McVicar, Brian (30 June 2022). "Perrigo unveils new North American Corporate Headquarters on Grand Rapids' Medical Mile". mlive. Retrieved 27 October 2022.
- ^ Cantillion (21 December 2018). "The terrible irony of Perrigo's tax planning". Irish Times.
- ^ Charly Grant (21 December 2018). "Perrigo Tax Shocker Couldn't Come at Worse Time". Wall Street Journal.